Burning Rock Biotech (BNR) Operating Expenses (2020 - 2025)
Historic Operating Expenses for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$16.2 million.
- Burning Rock Biotech's Operating Expenses rose 1311.06% to -$16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$71.8 million, marking a year-over-year increase of 3513.53%. This contributed to the annual value of -$98.6 million for FY2024, which is 3217.81% up from last year.
- Per Burning Rock Biotech's latest filing, its Operating Expenses stood at -$16.2 million for Q3 2025, which was up 1311.06% from -$16.7 million recorded in Q2 2025.
- Burning Rock Biotech's Operating Expenses' 5-year high stood at -$15.5 million during Q1 2025, with a 5-year trough of -$56.1 million in Q4 2021.
- Moreover, its 5-year median value for Operating Expenses was -$36.3 million (2023), whereas its average is -$35.5 million.
- In the last 5 years, Burning Rock Biotech's Operating Expenses plummeted by 11118.32% in 2021 and then surged by 4877.08% in 2024.
- Burning Rock Biotech's Operating Expenses (Quarter) stood at -$56.1 million in 2021, then grew by 17.63% to -$46.2 million in 2022, then grew by 25.49% to -$34.4 million in 2023, then skyrocketed by 31.82% to -$23.5 million in 2024, then skyrocketed by 31.2% to -$16.2 million in 2025.
- Its Operating Expenses stands at -$16.2 million for Q3 2025, versus -$16.7 million for Q2 2025 and -$15.5 million for Q1 2025.